Competition seen intensified for proton pump inhibitors market

As Ilyang Pharm is poised to join the PPI market by launching newly developed antiulcerant agent Noltec (ilaprazole) within this year, marketers may need to come up with more distinguished strategies, said an industry watcher.

Local pharmaceutical companies are stepping up their marketing in the proton pump inhibitor (PPI) market in Korea, which is forecast to become more competitive than ev...